According to Oyster Point Pharma's latest financial reports the company's current revenue (TTM ) is HK$0.15 Billion. In 2021 the company made a revenue of HK$0.19 Billion an increase over the revenue in the year 2020 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.